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ABSTRACT
Objective: Punica granatum (PG) contains anthocyanins which are useful as antioxidants, anti-inflammatory, and prevent cancer, while also increasing 
bone cell proliferation and osteoblasts differentiation in bone remodeling.
Methods: The reactivity of osteocalcin protein markers with PG polyphenol fractionation hydrogels observed using enzyme-linked immunosorbent 
assay, the degree of reactivity was determined by optical density at 550 nm.
Results: PG butanol fraction has better reactivity compared to the total extract, ethyl, and hexane fraction. Based on the reactivity distribution, bone 
morphogenetic protein (BMP)-2 and collagen Type-1 had a dominant distribution compared to osteocalcin, but the theses proteins had a strong 
relation (r = 0.8) with probability (P < 0.05).
Conclusion: PG butanol fraction had better reactivity to osteocalcin, BMP-2, and collagen Type-1 compared with total extract, hexane, and ethyl 
fraction. The four PG polyphenol fractionations have dominant reactivity to BMP-2.
Keywords: Punica granatum, Reactivity, Osteocalcin, Bone matrix protein-2, Collagen Type-1.
INTRODUCTION
Pomegranate (Punica granatum [PG]) peel contains proanthocyanidin 
which is a family of flavonoids [1]. This active component acts as an 
antioxidant, anticancer, and also anti-inflammatory by inhibiting pro-
inflammatory cytokines [2]. Moreover, these active components can also 
inhibit a number of enzymes that play a role in cell differentiation such 
as cyclooxygenase, lipooxygenase, cytochrome P450, phospholipase A2, 
ornithine decarboxylase, carbonic anhydrase, 17 beta-hydroxysteroid 
dehydrogenase, and serine protease [3].
PG peel extract contains various active components that differ 
depending on the extractor which used. The largest phenolic levels 
were found in butanol fraction compared to other extractors. The 
ethanol extract of PG peel produces a number of polyphenols which can 
trigger the expression of angiogenesis cells in the process of new bone 
formation [4]. A number of studies have reported that PG polyphenol 
fractionation has a significant effect on osteoblast cell viability as well 
as curcumin polyphenol fractionation as an immunostimulator for 
osteoblast expression in bone remodeling case [5]. The pomegranate 
peel of the Ganesh variety that extracted with ethanol and methanol 
was evaluated for the phenol content which contained at those extract. 
Methanol extract has better immunotolerant potency against pathogens 
than ethanol extract, while a mixture of ethanol and methanol extract 
has a very good antioxidant potency with phenol content in it which can 
act as an antibacterial either antioxidant [6].
Siddiqui et al. reported that PG can increase bone cell proliferation and 
osteoblast differentiation that is characterized by the expression of 
the runt-related transcription factor 2 (Runx2) gene. This assumption 
can be used as a reference for osteoporosis medication [7]. Meanwhile, 
PG ethanol extract can also be used as an anti-osteoporosis drug due 
to its ability to induce glucocorticoid hormones in osteoporosis mice 
model [8]. Furthermore, Bahtiar et al. reported that the use of PG 
polyphenol fractionation in concentrations of 50, 100, and 200 mg/kg 
can significantly prevent bone loss, this is related to an increase in 
bone calcium, particularly by increasing osteoblast [9], likewise in 
ovariectomy case, PG can be a stimulus to prevent bone loss [10]. The 
ability of PG in bone remodeling had been used to be a reference for this 
study, so the aim of this study was to test the ability of PG that interacts 
with proteins involved in bone remodeling such as osteocalcin, bone 
morphogenetic protein (BMP)-2, and collagen Type-1.
MATERIALS AND METHODS
Material
This study has passed ethical clearance from the Dentistry Faculty, 
North Sumatra University, Medan-Indonesia. This study used PG 
polyphenol fractionation as the assay material to measure the degree 
of reactivity from osteocalcin, BMP-2, and collagen Type-1 (Abcam, 
Cambridge, USA) proteins. The Enzyme-linked Immunosorbent Assay 
(ELISA) assay will be used to the reactivity analysis PG polyphenol with 
the bone marker proteins as the indicator of bone remodeling.
Extraction and fractionation of PG
The first stage is the extraction and fractionation of PG as a test material 
based on methods that had been done by Arma et al. [11]. 900 g of fresh 
PG peel that has been cleaned and peeled off, wind dried for 2×24 h, 
cut into small pieces and mashed. Subsequently macerated with 96% 
ethanol (1:10) 9 L for 24 h and stirred in the first 6 h. On the 2nd day, 
the macerate was filtered (macerate I), the pulp continued maceration 
with 96% ethanol (1:5) 4.5 L for 24 h. On the 3rd day, the macerate was 
filtered and merged with the macerate I. Furthermore, the solvent was 
evaporated so that a thick extract of 1164.4 g was obtained. Fractionation 
Research Article
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i12.29683
545
Asian J Pharm Clin Res, Vol 11, Issue 12, 2018, 544-547
 Burhan et al. 
was then carried out into polyphenols, where the extract was diluted 
with aquadest and then fractionated with 4×500 mL n-hexane which 
produced 3.25-g hexane fraction. Fractionation was then also carried 
out too with ethyl acetate 5×500 mL which obtained 13.9 g ethyl acetate 
fraction. Then, the least fractionation with 5×500 mL butanol was 
obtained 44 g butanol fraction.
Determination of total phenol levels was carried out using the Folin–
Ciocalteu method, by measuring the indicator of gallic acid. 4 mg 
gallic acid was dissolved in 10 mL ethanol (400 ppm) with various 
concentrations (30 ppm, 40 ppm, 50 ppm, 60 ppm, and 70 ppm). The 
absorbance of the solution was measured with the Folin–Ciocalteu 
method and carried out as follows: The sample was put into a plate, 
then 50 ml of Folin reagent 7.5% was added. 50 µl of a sample was 
put into it and incubated for 8 min, then added 1% NaOH followed 
by incubation for 1 h. The absorbance of gallic acid expression was 
measured by spectrophotometry at 730 nm. Determination of total 
phenolic levels equivalent of gallic acid was carried out using the Folin–
Ciocalteu method, with gallic acid as a comparison, assuming that all 
phenolics contained in the extract or fraction specified total phenolic 
content were considered as gallic acid or gallic acid equivalents.
Reactivity assay by ELISA
The ELISA technique was adopted from Gani et al. [12] to find out the 
lowest concentration of the PG fraction which still shows reactivity 
to bone marker proteins (osteocalcin, BMP-2, and collagen Type-1). 
Then, the concentration of the test material was measured based on 
optical density (OD) at 655 nm. The OD that obtained was used to get 
the concentration based on the conversion with the standard formula 
(OD×7.65) −0.3=µg/ml).
The ELISA test was carried out by entering 200 µl of each PG polyphenol 
fractionation sample to 96-well plate (triplo) which had been converted 
to its concentration value and shaken at 200× g for 5 min, then incubated 
at room temperature for 1 h and washed with Tween-20 for 3 times. 
Furthermore, in each well was added 200 µl of 5% non-fat milk and 
incubated on a shaker for 1 h at room temperature and washed with 
Tween-20 for 3 times. After that, each marker protein for osteocalcin, 
BMP-2, and collagen Type-1 was dissolved in 5% non-fat milk with a 
ratio of 1:2000, diluted to get a concentration of 100 µg/ml, then put 
into the well.
In the first well was added 200 μl of each bone marker protein and 
the next well was 100 μl each, then dilution was carried out leveled 
8 times, sequentially (1000, 500, 250, 125, 62.5, 31.25, 18.62, and 
7.81) after that incubated on a shaker for 1 h at room temperature and 
washed with Tween-20 for 3 times. In each well was added 100 µl of 
anti-protein marker antibody (HRP - rabbit anti-osteocalcin, BMP-2, 
and collagen Type-1 IgG (H+L) with a ratio of 1:5000 and incubated 
on a shaker for 1 h at room temperature, then washed with Tween-20 
solution for 3 times. Moreover, in each well was added 50 µl of ELISA 
substrate solution and placed in a dark room for 20 min. The reaction 
that occurred between PG polyphenol fractionation and bone marker 
protein was stopped by adding 50 mL of HCl 1 N. The result was read 
with an ELISA reader based on OD at 550 nm.
Statistical analyses
PG polyphenol fractionation percentage profile which identified 
by bone marker protein was analyzed using parametric and non-
parametric tests with p<0.05 as a determinant of statistical significance 
and correlation (r=1) as a determinant of the relationship between the 
analyzed variables.
RESULTS AND DISCUSSION
The gallic acid of PG polyphenol fractionations has value above 
equivalent to 150 mg/ml. The butanol fraction has gallic acid equivalent 
(157.62 mg/ml) more dominant than hexane fraction (113.81 mg/ml), 
ethyl fraction has 155.90 mg/ml, and extract total (ethanol extract) of 
PG has 169.61 mg/ml of gallic acid.
Bone formation metabolism consists of the balance of matrix deposition, 
mineral formation, and reabsorption [13]. The herbs used had been 
reported to have an effect on the process of new bone formation, 
specifically inhibiting bone reabsorption. Garlic and parsley have been 
reported could inhibit bone reabsorption and osteoclast activity which 
causes an increase in mineral density in ovariectomy cases [14]. PG 
has 50% active components, where phenolics and flavonoids are the 
dominant ones and very important as phytochemicals [15]. In addition, 
there are 40% water, sugar, pectin, and organic acids such as ascorbic 
acid, either 10% fibers, vitamins (E, C, and K), polysaccharides, and 
minerals [16].
Based on measurements of total phenolic from extraction and 
fractionation, PG phenolic levels were found to be quite high, especially 
in the butanol fractionation. These results proved that ethanol extract 
from PG peel produces optimal polyphenols in triggering angiogenesis-
osteoblast cells by inducing osteocalcin, BMP-2, and collagen type-1. 
This way gives the possibility of PG can play a role in bone remodeling. 
PG has a number of active components that contribute to bone repair by 
inducing bone marker proteins [17]. The results of this study showed 
that PG polyphenol fractionation has good reactivity to all three bone 
marker proteins (Figs. 1-3).
ELISA test used a based concentration to measure the lowest 
concentration titers that still show good reactivity. This study used 
eight different concentrations (µg/ml) (1000, 500, 250, 125, 62.5, 
31.25, 18.62, and 7.81). The results of OD (550 nm) was obtained scale 
reactivity 1.11> (strong), 1.1–1.10 (medium), and <1.09 (low). From 
these results, each PG polyphenol fractionation was averaged to obtain 
a percentage value of bone marker reactivity as shown in Figs. 1-3.
Fig. 1: Reactivity of osteocalcin protein on the Punica granatum 
polyphenol
Fig. 2: Reactivity of bone morphogenetic protein-2 protein on the 
Punica granatum polyphenol
546
Asian J Pharm Clin Res, Vol 11, Issue 12, 2018, 544-547
 Burhan et al. 
PG butanol fraction has a very strong reactivity to osteocalcin, followed 
by hexane and ethyl fractionation (Fig. 1). PG polyphenols are reported 
to play a role in the osteogenic activity. Giving PG with concentrations 
of 10, 100, 1000, and 10,000 μg/ml can increase the number of 
cartilage nodules in cartilage formation, so it can be recommended 
that PG can increase bone formation [18]. Osteocalcin protein plays a 
role in bone calcium formation, with a molecular weight 5.8 KDa and 
amounts about 10–12% of the total non-collagen protein, this protein is 
closely related to the bone mineralization phase [19]. Some other bone 
proteins such as thrombopoietin, glycoprotein acids, and fibronectin 
are proteins that contain arginine-lysine aspartate acid which has 
a large affinity for calcium formation, these proteins have the ability 
to be bound by integrin receptors [20]. Growth factors and cytokines 
such as transforming growth factor beta (TGF-β), insulin growth factor, 
interleukin, and BMP are present in small amounts in the bone matrix, 
where the protein binds bone mineral and the matrix will then release 
during bone resorption by osteoclasts [21].
Osteocalcin serum was reported acts as a marker of bone turnover 
associated with osteoporosis [22]. In general, osteocalcin serum can 
increase new bone formation [23]. Lansky et al. reported that the 
amount of substance from PG ellagic acid can increase the signal for new 
bone formation [24]. Wnt/β-catenin from PG is an active component 
that acts to increase the signal for osteogenesis increased. Specifically, 
ellagic acid can increase osteopontin and osteocalcin [25]. PG seed oil 
extract was reported to play a role as a bone biomarker, specifically 
to detect osteocalcin [26]. This activity linked with the increase of the 
Runx2 gene (p<0.001) which triggers the expression of proteins that 
involved in new bone formation. This indicated that PG can prevent 
bone loss by increasing the activity of inflammatory responses and 
stress oxidative [4].
Fig. 2 shows BMP-2 bone markers having excellent reactivity to PG 
butanol fractionation, even though all PG polyphenol fractionations had 
strong reactivity against BMP-2. The proliferation and differentiation of 
osteoblasts mediated by growth factors such as BMPs, TGF-β, and core-
binding factor alpha 1, which are reported as osteogenic receptor targets 
associated with the Runx2 [27]. This indicated that PG polyphenols 
fractionations may be able to induce the expression of BMP-2 when bone 
remodeling occurs by maintaining osteoblast activity and controlling 
osteoclast [28]. Giving PG with a concentration of 100 μg/ml can 
increase bone nodule formation which illustrated the occurrence of 
osteoblast differentiation within 21 days [29], by increasing calcium 
and osteoblasts as an indicator of BMP-2 expression [30]. Giving PG 
with this concentration can increase calcium deposits up to 68.85% 
(p<0.001) compared to controls. This ability is a form of an extracellular 
matrix that can regulate osteogenic tissue expression [31]. The results 
also showed that PG polyphenol fractionation has the ability to bind the 
osteocalcin, BMP-2, and collagen Type-1 starting at concentrations of 
1000, 500, 250, 125, 62.5, 31.25, 18.62, and 7.81 µg/ml.
The collagen Type-1 has a very good sensitivity to PG butanol 
fractionation (Fig. 3) and the PG better than effect reactivity to BMP-2 
compared the osteocalcin and collagen Type-1 (Fig. 4). In line with 
other studies using butanol fractionation of L. ferrugineus extract 
also had better results compared to other fractionation in inhibiting 
phenylephrine at aortic cardiovascular disorders [32]. PG can improve 
the function of osteoblasts which play an important role in bone 
remodeling by inducing the expression of bone collagen protein 
(collagen Type-1) which indicates that PG has anti-osteoporosis ability 
and can be used as an alternative herb for new bone repair [7]. The 
results were in line with this study (Table 1) which showed osteocalcin, 
BMP-2, and collagen Type-1 had significant differences when tested 
with PG polyphenols fractionations (p<0.05). Research using mice 
model shown that collagen Type-1 can improve implant bone 
remodeling [33]. In addition, BMP-2 was also involved in maintaining 
osteoblasts balance to maintain bone integrity [34]. The result from PG 
polyphenols fractionations which were tested with osteocalcin, BMP-2, 
and collagen Type-1 markers indicating that PG can be used as an herbs 
alternative in bone remodeling after endodontic movement.
Meanwhile using ANOVA one-way test as shown in Table 1, BMP-2 had 
a normal distribution data with significant differences results between 
all of PG polyphenol fractionations (p<0.05) with a strong correlation 
(r=0.8). Furthermore, non-parametric statistics with Mann–Whitney 
test showed osteocalcin had significant differences between all PG 
Fig. 3: Reactivity of collagen Type-1 protein on the 
Punica granatum polyphenol
Fig. 4: Distribution and frequency reactivity of bone marker 
protein (osteocalcin, bone morphogenetic protein-2, and collagen 
Type-1) to the Punica granatum polyphenol
Table 1: Statistical analysis of bone marker protein in various Punica granatum polyphenol
Protein bone 
marker









Mean±SD p r Analysis
Osteocalcin 1.12 1.17 1.01 1.189 1.073±0.01 p<0.05 0.6 Non-parametric
BMP-2 1.59 1.83 1.61 2.06 1.148±0.01 p<0.05 0.8 One-way ANOVA
Collagen Type-1 1.34 1.14 0.89 2.06 1.150±0.01 p<0.05 0.8 Non-parametric
P. granatum: Punica granatum, BMP: Bone morphogenetic protein
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polyphenol fractionations (p<0.05) with Spearman’s correlation 
(r=0.6). Other than that, collagen Type-1 also had significant differences 
between all PG polyphenol fractionations based on the Friedman test 
(p<0.05) with a strong relationship based on Spearman’s correlation 
(r=0.809).
CONCLUSION
The PG butanol fractionation had better reactivity to osteocalcin, 
BMP-2, and collagen Type-1 compared to total extracts, hexane, and 
ethyl fractions. In general, the four PG polyphenol fractionations have 
the dominant reactivity to BMP-2.
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